Remove Disease Remove Doctors Remove Vaccine Remove Virus
article thumbnail

Where is the Ignite Theater tech leading us?

Drug Discovery World

For the patient as well as for doctors, this means creating more time to make decisions, as the company believes: “Patients – and their quality of life – shouldn’t have to wait for a broken system to provide an answer six months too late.

Vaccine 147
article thumbnail

Women in STEM with Delphine Guyon-Gellin

Drug Target Review

DGG: At Osivax, we’re working on a new class of vaccines that target invariant parts of mutating viruses; this approach is disruptive and very different from conventional vaccines. Last summer, we published a first signal of efficacy in humans in the LANCET Infectious Diseases for our lead broad-spectrum influenza candidate, OVX836.

Vaccine 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

mRNA vaccines slash risk of COVID-19 infection by 91% in fully vaccinated people

The Pharma Data

People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of eight sites, including Salt Lake City. Those who unfortunately got COVID-19 despite being vaccinated were still better off than those who didn’t.”

Vaccine 52
article thumbnail

Answering Your Qs on the New COVID Vaccines

The Pharma Data

11, 2021 — As the rollout of the COVID-19 vaccines continues, scores of questions are emerging. How do the COVID-19 vaccines work? The COVID-19 vaccines work by teaching the immune system to protect against the virus, experts said. ” Can the vaccines make you sick? MONDAY, Jan.

Vaccine 52
article thumbnail

Facebook Posts Big Drivers in Vaccine Resistance, Study Finds

The Pharma Data

8, 2021 — As Americans await their COVID-19 shot, a new study of a different vaccine shows the power of Facebook posts in fueling “anti-vax” resistance to immunization. The study included more than 10 years of public Facebook posts on the human papillomavirus (HPV) vaccine. Centers for Disease Control and Prevention.

Vaccine 52
article thumbnail

Annaliesa Anderson, Ph.D., Will Lead Pfizer’s Vaccine Research & Development 

The Pharma Data

has been appointed Senior Vice President and Head of the Company’s Vaccine Research & Development (R&D) organization effective August 1, succeeding Kathrin U. Annaliesa is a world-class scientist with a track record of delivering both vaccines and therapeutics in pioneering new areas of science and where there is urgent unmet need.

Vaccine 40
article thumbnail

NEW STORAGE OPTION FOR PFIZER-BIONTECH VACCINE, EASING DISTRIBUTION AND STORAGE OF DOSES ACROSS EUROPEAN UNION

The Pharma Data

The new data is a testament to the companies’ ongoing commitment to developing this vaccine further and collecting data in order to support broader and more flexible vaccine distribution and inoculation. From the beginning our goal was to make our vaccine broadly available to people around the world. Source link:[link].

Vaccine 52